Singular Genomics Systems Inc (OMIC)
0.4049
+0.02
(+4.11%)
USD |
NASDAQ |
Apr 19, 15:05
Singular Genomics Systems Total Assets (Quarterly): 265.47M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 265.47M |
| September 30, 2023 | 284.52M |
| June 30, 2023 | 283.98M |
| March 31, 2023 | 305.47M |
| December 31, 2022 | 327.98M |
| September 30, 2022 | 345.48M |
| June 30, 2022 | 366.41M |
| Date | Value |
|---|---|
| March 31, 2022 | 342.11M |
| December 31, 2021 | 355.65M |
| September 30, 2021 | 370.83M |
| June 30, 2021 | 383.98M |
| March 31, 2021 | 155.62M |
| December 31, 2020 | 30.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.50M
Minimum
Dec 2020
383.98M
Maximum
Jun 2021
293.69M
Average
327.98M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 4.250B |
| Azenta Inc | 2.824B |
| Harvard Bioscience Inc | 137.37M |
| Bionano Genomics Inc | 214.40M |
| Akoya Biosciences Inc | 180.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 86.46M |
| Shareholders Equity (Quarterly) | 179.01M |
| Debt to Equity Ratio | 0.0497 |
| Current Ratio | 10.51 |
| Net Debt Paydown Yield | 0.72% |